Xavier Saelens had his B.S. degree from Ghent University, Ghent, Belgium, in 1985, then an M.S. degree from the same university in 1987, and a Ph.D. degree in biotechnology, Ghent University, in 1990. From 2004 to 2010, he has been working as an Assistant Professor at the Department for Molecular Biomedical Research, Ghent University and between 2009 and 2013, he will serve as a Professor in molecular virology at the same university. Saelens is a Member of the Belgian Society of Biochemistry and Molecular Biology, the Belgian Society for Microbiology, the Belgian Society for Immunology, and the International Society for Vaccines. Since 2004, he has worked as a lecturer in molecular virology for Master students in biochemistry and biotechnology, a colecturer in general microbiology for Bachelor students in biochemistry and biotechnology, and a colecturer in gene technology for Bachelor students in biochemistry and biotechnology, all in Ghent University. His research interests focused on the development of a universal influenza A and B vaccine: improving vaccine design, elucidating mechanism of action and development of novel influenza B vaccines (since 2004); the role of mitochondrial proteins and function in cell death with focus on Bid and Htra2/OMI (2000–2005); control of protein synthesis in apoptosis and necrosis (1999–2004), recombinant influenza virus gene and protein vaccine development (1996–1999); heterologous expression of influenza A virus hemagglutinin and neuraminidase in yeasts and filamentous fungi (1991–1995); cloning and molecular characterization of the RNA-dependent RNA polymerase of tobacco necrosis virus and its expression in transgenic Nicotiana tabacum (1987–1990).
Biography Updated on 6 September 2009